Congenital rubella syndrome: The end is in sight

British Journal of Ophthalmology

Volumn 91, Issue 11, 2007, Pages 1418-1419

  Lambert, Scott R ^a  

^a EMORY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RUBELLA ANTIBODY; RUBELLA VACCINE;

BONE DISEASE; CATARACT; CLINICAL FEATURE; CONGENITAL GLAUCOMA; CONGENITAL HEART DISEASE; CONGENITAL RUBELLA SYNDROME; DEVELOPING COUNTRY; EDITORIAL; ERADICATION THERAPY; HEALTH PROGRAM; HERD IMMUNITY; HIGH RISK POPULATION; HUMAN; IMMIGRATION; MENINGOENCEPHALITIS; MENTAL DEFICIENCY; MICROCEPHALY; NEWBORN JAUNDICE; OUTCOME ASSESSMENT; PATIENT; PRIORITY JOURNAL; PURPURA; RETINA PIGMENT DEGENERATION; RISK FACTOR; SPLENOMEGALY; VACCINATION; WORLD HEALTH ORGANIZATION;

DEVELOPING COUNTRIES; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INTERNATIONAL COOPERATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RUBELLA SYNDROME, CONGENITAL; RUBELLA VACCINE;

EID: 35748959904     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.117960     Document Type: Editorial

References (15)

1. Gregg NM. Congenital cataract following German measles in the mottier. Transactions of the Ophthalmological Society of Australia 1941;3:35-46.
2. CDC. Achievements in public health: Elimination of rubella and congenital rubella syndrome - United States, 1969-2004. MMWR Weekly 2005;54:279-82.
3. Dayan GH, Castillo-Solorzano C, Nava M, et al. Efforts at rubella elimination in the United States: The impact of hemispheric rubella control. CID 2006;43(Suppl):S158-63.
4. Robertson SE, Featherstone DA, Gacic-Dobo M, et al. Rubella and congenital rubella syndrome: global update. Rev Panam Salud Publica/Pan Am J Public Health 2003;14:306-15.
5. Cutts FT, Best J, Siqueira MM, et al. Vaccine Assessment and Monitoring Team of the Department of Vaccines and Biologicals. Guidelines for surveillance of congenital rubella syndrome and rubella, Field test version, May 1999. Geneva: WHO, December, 1999.
6. Vaccine Assessment and Monitoring Team of the Department of Vaccines and Biologicals. Control of rubella and congenital rubella syndrome (CRS) in developing countries. Geneva: WHO, March, 2000.
7. Sultana R, Rahman MM, Hassan Z, et al. Prevalence of IgG antibody against measles, mumps and rubella in Bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy. Scand J Immunol 2006;64:684-9.
8. Jarour N, Hayajneh WA, Balbeesi A, et al. Seroprevalence of rubella among Jordanian women of childbearing age. Vaccine 2007;18:3615-8.
9. Pehlivan E, Karaoglu L, Ozen M, et al. Rubella seroprevalence in an unvaccinated pregnant population in Malatya, Turkey. Public Health 2007;121:462-8.
10. Wang I-J, Huang IM; Chen HH, et al. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact. J Med Virol 2007;79:97-103.
11. Eckstein M, Vijayalakshmi P, Killedar M, et al. Aetiology of childhood cataract in south India. Br J Ophthalmol 1996;80:628-32.
12. Vijayalakshmi P, Srivastava KK, Poornima, et al. Visual outcome of cataract surgery in children with congenital rubella syndrome. J AAPOS 2003;7:91-5.
13. Cutts FT, Robertson SE, Diaz-Ortega J-L, et al. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part 1: burden of disease from CRS. Bull World Health Organ 1997;75:56-68.
14. Vijayalakshmi P, Rajasundari TA, Prasad NM, et al. Prevalence of eye signs in congenital rubella syndrome in South India: A role for population screening. Br J Ophthalmol 2007;91:1467-70.
15. Muller CP, Kremer JR, Best JM, et al. WHO Steering Committee for Measles and Rubella. Reducing global disease burden of measles and rubella: Report of the WHO Steering Committee on research related to measles and rubella vaccines, 2005. Vaccine 2007;25:1-9.